Tag: phase III
-
Nation & World
Targeted drug shows promise in advanced kidney cancer
Harvard researchers at Dana-Farber Cancer Institute have developed a novel targeted drug that shows promise in advanced kidney cancer by interfering with the abnormal blood vessel formation that fuels tumor growth.
3 minutes